Corporate Member Update-Seattle Genetics: A product-specific J-code for an mUC treatment is now available

Corporate Member Update-Seattle Genetics: A product-specific J-code for an mUC treatment is now available

PADCEV™
July, 2020

We are sending this communication on behalf of Astellas Pharma US, Inc. and Seattle Genetics to announce the assignment of a product-specific, permanent J-code for PADCEV. The Centers for Medicare & Medicaid Services (CMS) released the July 2020 Quarterly Healthcare Common Procedural Coding System (HCPCS) File, which includes the designation of J9177 for PADCEV with the effective date of July 1, 2020.

Read the full press release.

 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members